Targets and Effective Constituents of ZhiziBaipi Decoction for Treating Damp-Heat Jaundice Syndrome Based on Chinmedomics Coupled with UPLC-MS/MS

por Wei, Wen-feng, Sun, Hui, Liu, Shao-bo, Lu, Sheng-wen, Zhang, Ai-hua, Wang, Wan-ying, Chai, Wen-jun, Wu, Fang-fang, Yan, Guang-li, Guan, Yu, Wang, Xi-jun
Publicado 2022

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer

por Ji, Peng, Gong, Yue, Jin, Ming-liang, Wu, Huai-liang, Guo, Lin-Wei, Pei, Yu-Chen, Chai, Wen-Jun, Jiang, Yi-Zhou, Liu, Yin, Ma, Xiao-Yan, Di, Gen-Hong, Hu, Xin, Shao, Zhi-Ming
Publicado 2022

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial

por Wu, Song-Yang, Xu, Ying, Chen, Li, Fan, Lei, Ma, Xiao-Yan, Zhao, Shen, Song, Xiao-Qing, Hu, Xin, Yang, Wen-Tao, Chai, Wen-Jun, Guo, Xiao-Mao, Chen, Xi-Zi, Xu, Yan-Hui, Zhu, Xiao-Yu, Zou, Jian-Jun, Wang, Zhong-Hua, Jiang, Yi-Zhou, Shao, Zhi-Ming
Publicado 2022

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

por Chen, Li, Jiang, Yi-Zhou, Wu, Song-Yang, Wu, Jiong, Di, Gen-Hong, Liu, Guang-Yu, Yu, Ke-Da, Fan, Lei, Li, Jun-Jie, Hou, Yi-Feng, Hu, Zhen, Chen, Can-Ming, Huang, Xiao-Yan, Cao, A-Yong, Hu, Xin, Zhao, Shen, Ma, Xiao-Yan, Xu, Ying, Sun, Xiang-Jie, Chai, Wen-Jun, Guo, Xiaomao, Chen, Xizi, Xu, Yanhui, Zhu, Xiao-Yu, Zou, Jian-Jun, Yang, Wen-Tao, Wang, Zhong-Hua, Shao, Zhi-Ming
Publicado 2022